Perrigo Company plc Repayments of Debt
Perrigo Company plc (PRGO) reported Repayments of Debt of $24.70 million for the 6-month period ending 2019-06-29, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2019-08-08
- Perrigo Company plc repayments of debt for the quarter ending 2019-06-29 was $12.40M.
- Perrigo Company plc repayments of debt for the quarter ending 2019-03-30 was $12.30M.
- Perrigo Company plc repayments of debt for the quarter ending 2017-12-31 was $367.30M.
- Perrigo Company plc repayments of debt for the quarter ending 2017-09-30 was $14.60M.
- Perrigo Company plc repayments of debt for fiscal 2017 was $2.61B.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2019-06-29 | $12.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $24.70M 10-Q · filed 2019-08-08 | ||
| 2019-03-30 | $12.30M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $367.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $381.90M derived: sum of 2 quarters · filed 2018-03-01 | $2.61B 10-K · filed 2018-03-01 | |
| 2017-09-30 | $14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.24B 10-Q · filed 2017-11-09 | ||
| 2017-07-01 | $2.23B 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |